WO1998021215A1 - Composition de phospholipides - Google Patents
Composition de phospholipides Download PDFInfo
- Publication number
- WO1998021215A1 WO1998021215A1 PCT/JP1997/004097 JP9704097W WO9821215A1 WO 1998021215 A1 WO1998021215 A1 WO 1998021215A1 JP 9704097 W JP9704097 W JP 9704097W WO 9821215 A1 WO9821215 A1 WO 9821215A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phospholipid
- phospholipid composition
- composition
- deionized water
- concentration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
- C07F9/103—Extraction or purification by physical or chemical treatment of natural phosphatides; Preparation of compositions containing phosphatides of unknown structure
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
- Y10S516/905—Agent composition per se for colloid system making or stabilizing, e.g. foaming, emulsifying, dispersing, or gelling
- Y10S516/907—The agent contains organic compound containing phosphorus, e.g. lecithin
Definitions
- the present invention relates to phospholipid compositions. More specifically, the present invention relates to a phospholipid composition which can hardly cause emulsification destruction and decrease in pH at the time of heat sterilization of an emulsion produced using the phospholipid composition as an emulsifier. Background technology
- phospholipid compositions have been made from natural phospholipid-containing materials, such as egg yolk, soybeans, or other products, but the method of preparation varies depending on the source. It is effective to extract the phospholipid component by the action of alcohol and then remove the alcohol to produce the product. At this time, if necessary, further neutralize the neutral lipid by purifying it with acetone. This is also commonly done.
- the phospholipid composition thus obtained has been widely used as an emulsifier in pharmaceuticals, cosmetics, foods, etc., but when used as an emulsifier in these fields, phospholipid pirates are used as an emulsifier.
- Emulsions e.g., fat emulsions
- Emulsions are usually heat-sterilized before use, so they are resistant to heat sterilization, that is, less susceptible to destruction of the milk, and are more resistant to pH reduction during sterilization. Is also strongly sought to have little change.
- conventional phospholipid compositions have not always been satisfactory in these respects.
- an object of the present invention is to provide a novel phospholipid composition that does not easily cause the above-described problems. Disclosure of the invention
- the present inventors have conducted various studies to achieve the above object, and as a result, completed the present invention.
- the present invention relates to a phospholipid composition containing two or more types of phospholipids, wherein a liquid suspended in deionized water at a concentration of 5% by weight has an electric conductivity of 130 to 2%. It is intended to provide a phospholipid composition characterized by being in the range of 20 S / cm and the pH of the solution is in the range of 6.5 to 9.5.
- the present invention provides a method for producing the above phospholipid composition, and an emulsifier comprising the phospholipid composition.
- the phospholipids include phosphatidylcholine, phosphatidylethanolanolamine, phosphatidylinositol, phosphatidylserine, phosphatidic acid, lysates thereof, and sphingomyelin.
- the term “phospholipid composition” refers to a composition containing two or more of these phospholipids, a phospholipid content of 20% or more, and the others mainly composed of neutral lipids. Specifically, it is usually extracted from egg yolk with an organic solvent (alcohol) and contains at least 20% of phospholipids, or is purified to have a phospholipid content of 80% or more. Which contains at least 50% of phospholipids, usually obtained by dehydrating the wet gum obtained in the degumming step in the soybean salad oil production process, or at least obtained by purifying it. Examples include those containing 80% of phospholipids.
- the phospholipid composition of the present invention has a conductivity of 130 to 220 / SZ cm of a liquid obtained by suspending such a phospholipid composition in deionized water to a concentration of 5% by weight.
- Example And the ⁇ of the liquid is in the range of 6.5 to 9.5.
- deionized water refers to fresh water from which dissolved ions have been removed, and specifically, has a conductivity of 2 SZcm or less.
- the “liquid suspended to a concentration of 5% by weight” is a ratio of 5 parts by weight of the phospholipid composition to 95 parts by weight of deionized water, for example, a homogenizer or the like. Refers to a liquid in which is dispersed in deionized water.
- the electric conductivity in the present invention is the electric conductivity of the above-mentioned suspension, and is 20 ° using an electric conductivity meter (for example, “Conductivity meter DS-14” manufactured by HORIBA, Ltd.).
- PH refers to the value measured at C.
- the pH is the pH of the above suspension and was measured at 20 ° C using a pH meter (for example, “pH meter F-22” manufactured by HORIBA, Ltd.) The value at the time.
- the phospholipid composition of the present invention has an electric conductivity in the above-mentioned range, for example, in order to facilitate the occurrence of the following. More preferably, it is in the range of 150 to 200 S / cm.
- the pH is lower than 6.5, even when the electric conductivity is in the range of 130 to 220 ⁇ S / cm, the emulsion produced using the phospholipid composition as an emulsifier cannot be sterilized by heating. If the pH is higher than 9.5, not only the emulsification is likely to occur during heat sterilization of the emulsified product but also the pH drop will increase. It is also indispensable that it is within the range. More preferably, the pH is in the range of 7.0 to 9.0.
- the phospholipid composition of the present invention contains two or more phospholipids. If the phospholipid composition contains only one type of phospholipid, the liquid suspended in deionized water to a concentration of 5% by weight has an electrical conductivity of 130 to 220 ⁇ 3 / (: ⁇ ). Range and the pH of the solution is in the range of 6.5 to 9.5, Emulsions produced using the resulting products as emulsifiers are susceptible to emulsification breakdown during heat sterilization. A typical method for producing such a phospholipid composition of the present invention will be described below.
- Crude phospholipid pirates obtained by removing alcohol from the extract obtained by allowing alcohol to act on dried egg yolk, Phosphorus whose purity is increased to 80% or more, for example, 95 to 99%, by removing the neutral lipids (triacylglycerol, cholesterol, etc.) by treating with 0 times the amount of acetone Dissolve the lipid composition in 3 to 20 times the amount of a polar solvent (methanol, ethanol, dichloromethane, acetone, water, etc.) or a polar solvent and a non-polar solvent (n-pentane, n-hexane, chloroform, acetic acid) Ethyl, ether, benzene, etc.) so that the electric conductivity is in the range of 130 to 220 SZ cm and the pH is in the range of 6.5 to 9.5. After contacting the solution with ion exchange resin, Is distilled off under reduced pressure.
- a polar solvent methanol, ethanol, dichloromethane,
- Examples of the ion exchange resin used in the above method and the like include a strongly acidic or weak cation exchange resin (examples of the former: Amberlite IR120B, IE200C (all manufactured by Rohm ⁇ Haas), Dowex 50w, MSC-1 [all Dow Chemical Co .; DouLite C-20, C-25D (all manufactured by Diamond Shamrock), etc .; Examples of the latter: Amberlite IRC50, IEC84, Dowex CCR-2, DouLite CC-4, etc.), or strongly basic Or weakly basic anion exchange resins (examples of the former: Amberlite IRA400. IRA900, Dowex 1, DouLite A-101D, etc .; examples of the latter: Amberlite IRA68, IEA45, etc.), which are used alone or If necessary, a plurality of them may be used as a mixture.
- a strongly acidic or weak cation exchange resin examples of the former: Amberlite IR120B, IE200C (all manufactured by Rohm ⁇ Haas
- Example 1 means% by weight.
- the solvent (alcohol) was removed under reduced pressure, followed by treatment with 6 times the amount of acetone to obtain the following purified egg yolk phospholipid composition.
- a phospholipid composition having the following composition having an electric conductivity of 172 / S Z cm and a pH of 7.5.
- the wet gum obtained in the degumming step in the salad oil manufacturing process was treated with 5 times the amount of acetone to obtain the following purified phospholipid composition.
- Example 1 the ratio of the strongly acidic cation exchange resin to the strongly basic anion exchange resin was not changed and the amount of the entire ion exchange resin used was variously changed, and the other conditions were the same as those in Example 1. Then, eight kinds of phospholipid compositions having different electric conductivities as shown in Table 1 below were prepared. The pH of these samples is also shown in Table 1 below. (Mouth) Preparation of emulsion (fat emulsion):
- Example Nos. 1 to 8 Total amount of 2 L (liter) is added gradually while stirring with a homomixer (manufactured by Tokushu Kika Kogyo Co., Ltd.) at 100,000 rpm for 10 minutes to obtain coarse milk. After the conversion, the high pressure homogenizer (made by Izumi Food Machinery Co., Ltd.) The mixture was finely emulsified by treating under a pressure of kg / cm 2 for 5 minutes to produce eight types of emulsions (fatty milk preparations) (Sample Nos. 1 to 8).
- the phospholipid composition has an electric conductivity in the range of 130 to 220 ⁇ SZ cm to prevent emulsification destruction, that is, to prevent emulsification stability and pH reduction, that is, to suppress pH reduction. It is understood that it is indispensable to be within. It can also be seen that a range of 150 to 200 ⁇ S / cm is preferable. Test example 2
- the electric conductivity adjusting liquid used was an aqueous solution containing 1 OmM concentration of Shio-dani potassium, Shio-dani sodium, calcium chloride, magnesium and iron chloride, respectively.
- the phospholipid debris has an electrical conductivity of 130. It can be seen that it is essential that the pH not only be within the range of ⁇ 220 ⁇ S / cm, but also within the range of pH 6.5-9.5. It is also found that the range of 7, 0 to 9.0 is preferable. Test example 3
- the exfoliated phospholipid obtained before treatment with the ion-exchange resin obtained according to Example 1 was purified according to the technique of high performance liquid chromatography disclosed in Japanese Patent Application Laid-Open No. 6-128278, and the phospholipid consisting of only phosphatidylcholine was used. A lipid composition was obtained.
- the high performance liquid chromatography was performed under the following conditions.
- Shiri gel all porous spherical shiri gel with a particle size of 40-60 m
- the content of phosphatidylcholine in the obtained phospholipid composition was 99.9%, the electric conductivity was 60; S / cm, and the pH was 5.1.
- Distilled water was added to 30 g of the phospholipid composition obtained above to make up to 600 g, and then dispersed with a high-speed homogenizer to prepare a 5% suspension.
- an aqueous sodium hydroxide solution and the electric conductivity adjusting solution used in Test Example 2 were added as appropriate, and then lyophilized to a pH of 7.3 to 7.5.
- four types of phospholipid compositions (Sample Nos. 16 to 19) having different electric conductivities were prepared.
- Table 3 shows the measurement and observation results.
- phospholipid fibers have an electrical conductivity of 130 to 220 to prevent emulsification destruction, that is, to prevent emulsification stability and pH decrease, that is, to suppress pH decrease. It can be seen that it is essential that not only the ⁇ S / cm and the pH be in the range of 6.5 to 9.5, but also that it contain two or more phospholipids. Industrial applicability
- the phospholipid composition of the present invention makes it difficult to cause emulsification destruction at the time of heat sterilization of an emulsion using the phospholipid composition as milk ⁇ J, and makes it relatively difficult to reduce pH at the time of heat sterilization. You get it. Therefore, accompanied by passing S3 ⁇ 4 opening heat sterilization in the production, for example pharmaceuticals, in various fields such as cosmetics and food, increased use as an emulsifier can be expected n
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69725969T DE69725969T2 (de) | 1996-11-13 | 1997-11-11 | Phospholipid-zusammensetzung |
US09/101,302 US6054494A (en) | 1996-11-13 | 1997-11-11 | Phospholipid composition |
EP97911511A EP0885896B1 (en) | 1996-11-13 | 1997-11-11 | Phospholipid composition |
JP51149198A JP3844508B2 (ja) | 1996-11-13 | 1997-11-11 | リン脂質組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8/302173 | 1996-11-13 | ||
JP30217396 | 1996-11-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998021215A1 true WO1998021215A1 (fr) | 1998-05-22 |
Family
ID=17905811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1997/004097 WO1998021215A1 (fr) | 1996-11-13 | 1997-11-11 | Composition de phospholipides |
Country Status (7)
Country | Link |
---|---|
US (1) | US6054494A (ja) |
EP (1) | EP0885896B1 (ja) |
JP (1) | JP3844508B2 (ja) |
KR (1) | KR100450501B1 (ja) |
CN (1) | CN1088461C (ja) |
DE (1) | DE69725969T2 (ja) |
WO (1) | WO1998021215A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009537298A (ja) * | 2006-05-15 | 2009-10-29 | ユニリーバー・ナームローゼ・ベンノートシヤープ | エマルジョンの調製方法 |
WO2018042576A1 (ja) * | 2016-08-31 | 2018-03-08 | キユーピー株式会社 | 卵黄リン脂質組成物およびその製造方法、ならびに該卵黄リン脂質組成物を用いた脂肪乳剤およびリポ化製剤 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1323353B1 (en) * | 2000-10-02 | 2009-04-01 | Fuji Oil Company, Ltd. | Fractionated soybean protein and process for producing the same |
CA2568483A1 (en) * | 2005-11-30 | 2007-05-30 | Meadwestvaco Corporation | Reminder system |
US20080234376A1 (en) * | 2007-03-21 | 2008-09-25 | Taiwan Liposome Company (A Taiwan Corporation) | Emulsion composition comprising prostaglandin e1 |
JP4959663B2 (ja) * | 2008-09-30 | 2012-06-27 | 富士フイルム株式会社 | 水性化粧料及びその製造方法 |
ES2767151T3 (es) * | 2012-10-24 | 2020-06-16 | Cargill Inc | Composición de emulsionante que contiene fosfolípidos |
AU2014203179C1 (en) | 2013-06-14 | 2017-05-04 | Aker Biomarine Antarctic As | Lipid extraction processes |
CN105746729B (zh) * | 2014-12-17 | 2021-11-30 | 丰益(上海)生物技术研发中心有限公司 | 乳化剂组合物及其用途 |
EP3700501A1 (en) | 2017-10-27 | 2020-09-02 | Cargill, Incorporated | Personal care product |
CN113201011B (zh) * | 2021-04-27 | 2022-05-24 | 内蒙古铂贝曼科技有限公司 | 一种磷脂加工助剂及其应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62263109A (ja) * | 1986-05-06 | 1987-11-16 | Pola Chem Ind Inc | リン脂質を安定に配合する方法 |
JPH0544952B2 (ja) * | 1986-02-10 | 1993-07-07 | Q P Corp | |
JPH06128278A (ja) * | 1992-10-15 | 1994-05-10 | Shokuhin Sangyo High Separeeshiyon Syst Gijutsu Kenkyu Kumiai | ホスファチジルコリンおよびその製造方法 |
JPH06321970A (ja) * | 1993-05-13 | 1994-11-22 | Kanagawa Kagaku Kenkyusho:Kk | ドコサヘキサエン酸を含むリン脂質組成物の取得方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4847015A (en) * | 1986-02-10 | 1989-07-11 | Kewpie Kabushiki Kaisha | Process for producing egg yolk lecithin having reduced PE content and/or containing substantially no impurities |
JPS6333387A (ja) * | 1986-07-28 | 1988-02-13 | Q P Corp | 中性脂質含量が減らされたリゾリン脂質含有リン脂質の製造法 |
JPH0657715B2 (ja) * | 1987-04-09 | 1994-08-03 | キユーピー株式会社 | Lpc以外のリゾ型リン脂質をほとんど含まないリゾリン脂質の製造方法 |
US5064655A (en) * | 1989-02-24 | 1991-11-12 | Liposome Technology, Inc. | Liposome gel composition and method |
US4944948A (en) * | 1989-02-24 | 1990-07-31 | Liposome Technology, Inc. | EGF/Liposome gel composition and method |
US5942639A (en) * | 1991-07-04 | 1999-08-24 | Asta Medica Aktiengesellschaft | Process for the preparation of alkylphosphocholines and the production thereof in pure form |
JPH0544952A (ja) * | 1991-08-08 | 1993-02-23 | Toshiba Corp | ドレンポンプの運転方法 |
JP3267868B2 (ja) * | 1995-08-29 | 2002-03-25 | キユーピー株式会社 | 卵黄リン脂質組成物 |
-
1997
- 1997-11-11 CN CN97191668A patent/CN1088461C/zh not_active Expired - Lifetime
- 1997-11-11 JP JP51149198A patent/JP3844508B2/ja not_active Expired - Lifetime
- 1997-11-11 WO PCT/JP1997/004097 patent/WO1998021215A1/ja active IP Right Grant
- 1997-11-11 US US09/101,302 patent/US6054494A/en not_active Expired - Lifetime
- 1997-11-11 DE DE69725969T patent/DE69725969T2/de not_active Expired - Lifetime
- 1997-11-11 KR KR10-1998-0705269A patent/KR100450501B1/ko active IP Right Grant
- 1997-11-11 EP EP97911511A patent/EP0885896B1/en not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0544952B2 (ja) * | 1986-02-10 | 1993-07-07 | Q P Corp | |
JPS62263109A (ja) * | 1986-05-06 | 1987-11-16 | Pola Chem Ind Inc | リン脂質を安定に配合する方法 |
JPH06128278A (ja) * | 1992-10-15 | 1994-05-10 | Shokuhin Sangyo High Separeeshiyon Syst Gijutsu Kenkyu Kumiai | ホスファチジルコリンおよびその製造方法 |
JPH06321970A (ja) * | 1993-05-13 | 1994-11-22 | Kanagawa Kagaku Kenkyusho:Kk | ドコサヘキサエン酸を含むリン脂質組成物の取得方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009537298A (ja) * | 2006-05-15 | 2009-10-29 | ユニリーバー・ナームローゼ・ベンノートシヤープ | エマルジョンの調製方法 |
WO2018042576A1 (ja) * | 2016-08-31 | 2018-03-08 | キユーピー株式会社 | 卵黄リン脂質組成物およびその製造方法、ならびに該卵黄リン脂質組成物を用いた脂肪乳剤およびリポ化製剤 |
Also Published As
Publication number | Publication date |
---|---|
KR100450501B1 (ko) | 2005-01-15 |
DE69725969T2 (de) | 2004-09-02 |
EP0885896A1 (en) | 1998-12-23 |
EP0885896A4 (en) | 2000-11-15 |
EP0885896B1 (en) | 2003-11-05 |
KR19990077132A (ko) | 1999-10-25 |
JP3844508B2 (ja) | 2006-11-15 |
CN1088461C (zh) | 2002-07-31 |
DE69725969D1 (de) | 2003-12-11 |
US6054494A (en) | 2000-04-25 |
CN1208419A (zh) | 1999-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4847015A (en) | Process for producing egg yolk lecithin having reduced PE content and/or containing substantially no impurities | |
US9994464B2 (en) | Method and devices for de-emulsifying and complexing organic compounds in emulsions | |
WO1998021215A1 (fr) | Composition de phospholipides | |
JP5185539B2 (ja) | スフィンゴミエリンおよびプラズマローゲン型グリセロリン脂質の製造方法 | |
JP3549598B2 (ja) | ポリグリセリン脂肪酸エステルの製造方法 | |
JP2987682B2 (ja) | 酸性リン脂質の濃縮法 | |
JP3100783B2 (ja) | ホスファチジルコリンおよびその製造方法 | |
JP4549719B2 (ja) | リン脂質組成物の製造方法及びこれを用いた医薬品組成物、化粧品組成物、又は食品組成物 | |
JPH0517918B2 (ja) | ||
JPS63279753A (ja) | 酵素改質レシチンの製造法 | |
JPH0657715B2 (ja) | Lpc以外のリゾ型リン脂質をほとんど含まないリゾリン脂質の製造方法 | |
KR101412434B1 (ko) | 정제 난황 인 지질 조성물의 제조 방법 및 이로써 얻어진 정제 난황 인 지질 조성물을 사용한 의약품 조성물, 화장품 조성물, 또는 식품 조성물 | |
GB2065659A (en) | Calciumphosphatidylchlorine- chloride, process for producing the same and pharmaceutical preparations containing the same | |
EP3508268B1 (en) | Egg yolk phospholipid composition and fat emulsion and lipolysis formulation using egg yolk phospholipid composition | |
JP3650168B2 (ja) | リゾ化リン脂質組成物及びその製造法 | |
JP2021020892A (ja) | 乳化組成物 | |
WO1987004711A1 (en) | Process for producing egg yolk lecithin containing a reduced amount of pe and/or containing substantially no impurities | |
JP6763521B2 (ja) | 2−dha−リゾホスファチジルコリン含有脂質組成物及びその製造方法 | |
JP2717510B2 (ja) | 苦味低減化剤の製造法 | |
Magdassi et al. | CHEMICAL INSTABILITY OP PHOSPHOLIPIDS: A KEY FACTOR IN STABILIZATION OF PERFLUOROCARBON EMULSIONS | |
JPH01197492A (ja) | レシチンの精製方法 | |
Wu | Soybean lecithin composition, fractionation, and functionality |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 97191668.3 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CN JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019980705269 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09101302 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997911511 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 1997911511 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019980705269 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1997911511 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019980705269 Country of ref document: KR |